Overview of Technegas for Radiopharmacies

An Introduction to Technegas® with Cyclomedica CEO James McBrayer In this video, Cyclomedica CEO James McBrayer introduces the powerful clinical value of Technegas®, explaining how its nanoparticle formulation enables precise, high-resolution ventilation imaging. With a proven track record in over 65 countries and now FDA-approved, Technegas® offers a trusted, efficient solution for diagnosing pulmonary embolism and other respiratory conditions. The video highlights not only its diagnostic strength but also its simplicity, speed, and seamless integration into nuclear medicine workflows.

The release as fetched from its publisher. cyclomedica.com ↗